<SEC-DOCUMENT>9999999995-26-001217-index.html : 20260417
<SEC-HEADER>9999999995-26-001217.hdr.sgml : 20260417
<ACCEPTANCE-DATETIME>20260417001515
ACCESSION NUMBER:		9999999995-26-001217
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20260416
DATE AS OF CHANGE:		20260417
EFFECTIVENESS DATE:		20260416

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kailera Therapeutics, Inc.
		CENTRAL INDEX KEY:			0002096997
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-294690
		FILM NUMBER:		26869298

	BUSINESS ADDRESS:	
		STREET 1:		180 THIRD AVENUE
		STREET 2:		4TH FLOOR
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		508-440-9475

	MAIL ADDRESS:	
		STREET 1:		180 THIRD AVENUE
		STREET 2:		4TH FLOOR
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>